Resources

For your patients with prediabetes (A1c of 5.7 to 6.4%), do you recommend they begin metformin even with providing them info on physical activity and nutrition? Follow the link to express your opinion!

56-year-old man, type 2 diabetes, had been prescribed SGLT-2 to lower his glucose levels. He had been taking an SGLT-2 for the past two years. His A1C, blood pressure and weight were elevated since the last visit 3 months ago. When asked if he was doing anything different, he said he had read articles and seen on TV about these types of medications causing heart disease, so he stopped taking his.

In part 4 of this exclusive video, Dr. Bakris contemplates the rate of potential false positives in an at-home kidney test for microalbuminuria, the possible causes of false positives and the need for patient education in the use of such tests.

In this week's Homerun Slides, therapeutic strategies to fight periodontal disease.

What makes a beta cell? The insulin-producing beta cell is perhaps the most intensely studied endocrine cell type, largely because of the implications for understanding the pathogenesis and treatment of diabetes.

Patients treated with standard therapy for blood glucose control show link between serious hypoglycemia and CAC progression, increasing risk of heart attack and stroke.

Liraglutide may help type 2 diabetes patients achieve tighter glycemic control with fewer side effects than exenatide.

Bromocriptine-QR may reduce CVD risk in type 2 patients independent of its effect on glycemic control.

Is the Diabetes Knowledge Test 2 (DKT2) a reliable way to show where you need to start in educating your patient for self-care?

Would you prefer a single-payer insurance program? Follow the link to cast your vote!